Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2018

20.11.2017 | Head and Neck

General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival

verfasst von: Hans Jørgen Aarstad, Arild Andrè Østhus, Helene Hersvik Aarstad, Stein Lybak, Anne Kari Hersvik Aarstad

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the 5- and 10-year survival prediction of health-related quality of life (HRQoL) scores obtained at diagnosis and at 6, 9 and 12 months after diagnosis in a cohort of curable head and neck squamous cell carcinoma (HNSCC) patients.

Materials and methods

HNSCC patients (n = 109) reported their HRQoL measured by the EORTC Quality of Life Questionnaire (QLQ) general (C30) questionnaire. At diagnosis, the included patients were below 78 years of age and at diagnosis planned treated with curative intent. Clinical variables and self-reported smoking, alcohol consumption and socio-demographic information were registered. From diagnostic blocks, we found 22 patients to be human papillomavirus (HPV) positive. New HRQoL scores were not obtained if the patient treatment changed from curative to palliative throughout the HRQoL data acquisition. Survival was determined from the National Population Register of Norway.

Results

Decreased survival with low HRQoL scores from EORTC QLQ scores was demonstrated with HRQoL scores obtained from different time points of the four time points studied. These survival predictions were mostly independent of HPV status, gender, age, TNM stage, tumor site, alcohol consumption, present smoking status and whether comorbidities were present at diagnosis; as well as to some extent with an adjustment of the same HRQoL score/index obtained at diagnosis. The specific indices “physical function”, “general pain” and “sleep disturbance” were in particular predictive of survival.

Conclusion

HRQoL scores obtained throughout the first year after diagnosis contained prognostic power to overall survival when measured both at 5 and 10 years of observation.
Literatur
1.
Zurück zum Zitat Klein J, Livergant J, Ringash J (2014) Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. Oral Oncol 50:254–262CrossRefPubMed Klein J, Livergant J, Ringash J (2014) Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. Oral Oncol 50:254–262CrossRefPubMed
2.
Zurück zum Zitat Verdonck-de Leeuw IM, van Nieuwenhuizen A, Leemans CR (2012) The value of quality-of-life questionnaires in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 20:142–147CrossRefPubMed Verdonck-de Leeuw IM, van Nieuwenhuizen A, Leemans CR (2012) The value of quality-of-life questionnaires in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 20:142–147CrossRefPubMed
3.
Zurück zum Zitat van Nieuwenhuizen AJ, Buffart LM, Brug J, Leemans CR, Verdonck-de Leeuw IM (2015) The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol 51:1–11CrossRefPubMed van Nieuwenhuizen AJ, Buffart LM, Brug J, Leemans CR, Verdonck-de Leeuw IM (2015) The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol 51:1–11CrossRefPubMed
4.
Zurück zum Zitat Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102CrossRefPubMedPubMedCentral Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J et al (2012) Global burden of human papillomavirus and related diseases. Vaccine 30(Suppl 5):F12-23PubMed Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J et al (2012) Global burden of human papillomavirus and related diseases. Vaccine 30(Suppl 5):F12-23PubMed
6.
Zurück zum Zitat Wang MB, Liu IY, Gornbein JA, Nguyen CT (2015) HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg 153:758–769CrossRefPubMed Wang MB, Liu IY, Gornbein JA, Nguyen CT (2015) HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg 153:758–769CrossRefPubMed
7.
Zurück zum Zitat Ljokjel B, Lybak S, Haave H, Olofsson J, Vintermyr OK et al (2014) The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol 134:636–645CrossRefPubMed Ljokjel B, Lybak S, Haave H, Olofsson J, Vintermyr OK et al (2014) The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol 134:636–645CrossRefPubMed
8.
Zurück zum Zitat Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I et al (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506:371–375CrossRefPubMed Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I et al (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506:371–375CrossRefPubMed
9.
Zurück zum Zitat Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2013) Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 139:14–20CrossRefPubMed Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2013) Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 139:14–20CrossRefPubMed
10.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
11.
Zurück zum Zitat Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441–2447CrossRefPubMed Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441–2447CrossRefPubMed
12.
Zurück zum Zitat Aarstad HJ, Vintermyr OK, Ulvestad E, Aarstad HH, Kross KW et al (2015) Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. APMIS 123:305–314CrossRefPubMed Aarstad HJ, Vintermyr OK, Ulvestad E, Aarstad HH, Kross KW et al (2015) Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. APMIS 123:305–314CrossRefPubMed
13.
Zurück zum Zitat Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Head and neck specific health related quality of life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol 47:974–979CrossRefPubMed Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Head and neck specific health related quality of life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol 47:974–979CrossRefPubMed
14.
Zurück zum Zitat Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clin Otolaryngol 36:361–368CrossRefPubMed Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clin Otolaryngol 36:361–368CrossRefPubMed
15.
Zurück zum Zitat Urba S, Gatz J, Shen W, Hossain A, Winfree K et al (2012) Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy. Oral Oncol 48:723–729CrossRefPubMed Urba S, Gatz J, Shen W, Hossain A, Winfree K et al (2012) Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy. Oral Oncol 48:723–729CrossRefPubMed
16.
Zurück zum Zitat Tarsitano A, Pizzigallo A, Ballone E, Marchetti C (2012) Health-related quality of life as a survival predictor for patients with oral cancer: is quality of life associated with long-term overall survival? Oral Surg Oral Med Oral Pathol Oral Radiol 114:756–763CrossRefPubMed Tarsitano A, Pizzigallo A, Ballone E, Marchetti C (2012) Health-related quality of life as a survival predictor for patients with oral cancer: is quality of life associated with long-term overall survival? Oral Surg Oral Med Oral Pathol Oral Radiol 114:756–763CrossRefPubMed
17.
Zurück zum Zitat Tsai WL, Chien CY, Huang HY, Liao KC, Fang FM (2013) Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma. Qual Life Res 22:715–723CrossRefPubMed Tsai WL, Chien CY, Huang HY, Liao KC, Fang FM (2013) Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma. Qual Life Res 22:715–723CrossRefPubMed
18.
Zurück zum Zitat Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R et al. (2016) Quality of life and performance status from a substudy conducted within a prospective phase 3 randomized trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for locally advanced head and neck carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. Int J Radiat Oncol Biol Phys Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R et al. (2016) Quality of life and performance status from a substudy conducted within a prospective phase 3 randomized trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for locally advanced head and neck carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. Int J Radiat Oncol Biol Phys
19.
Zurück zum Zitat Yang CJ, Roh JL, Kim MJ, Lee SW, Kim SB et al (2016) Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer. Qual Life Res 25:165–174CrossRefPubMed Yang CJ, Roh JL, Kim MJ, Lee SW, Kim SB et al (2016) Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer. Qual Life Res 25:165–174CrossRefPubMed
20.
Zurück zum Zitat Beisland E, Aarstad AK, Osthus AA, Aarstad HJ (2013) Stability of distress and health-related quality of life as well as relation to neuroticism, coping and TNM stage in head and neck cancer patients during follow-up. Acta Otolaryngol 133:209–217CrossRefPubMed Beisland E, Aarstad AK, Osthus AA, Aarstad HJ (2013) Stability of distress and health-related quality of life as well as relation to neuroticism, coping and TNM stage in head and neck cancer patients during follow-up. Acta Otolaryngol 133:209–217CrossRefPubMed
21.
Zurück zum Zitat Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J et al (2014) A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 120:302–311CrossRefPubMed Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J et al (2014) A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 120:302–311CrossRefPubMed
22.
Zurück zum Zitat Zikos E, Coens C, Quinten C, Ediebah DE, Martinelli F et al. (2016) The added value of analyzing pooled health-related quality of life data: a review of the EORTC PROBE initiative. J Natl Cancer Inst 108 Zikos E, Coens C, Quinten C, Ediebah DE, Martinelli F et al. (2016) The added value of analyzing pooled health-related quality of life data: a review of the EORTC PROBE initiative. J Natl Cancer Inst 108
23.
Zurück zum Zitat Lechner M, Fenton TR (2016) The genomics, epigenomics, and transcriptomics of hpv-associated oropharyngeal cancer–understanding the basis of a rapidly evolving disease. Adv Genet 93:1–56PubMed Lechner M, Fenton TR (2016) The genomics, epigenomics, and transcriptomics of hpv-associated oropharyngeal cancer–understanding the basis of a rapidly evolving disease. Adv Genet 93:1–56PubMed
24.
Zurück zum Zitat Grignon LM, Jameson MJ, Karnell LH, Christensen AJ, Funk GF (2007) General health measures and long-term survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133:471–476CrossRefPubMed Grignon LM, Jameson MJ, Karnell LH, Christensen AJ, Funk GF (2007) General health measures and long-term survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133:471–476CrossRefPubMed
25.
Zurück zum Zitat Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2013) Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients. Eur Arch Otorhinolaryngol 270:1721–1728CrossRefPubMed Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2013) Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients. Eur Arch Otorhinolaryngol 270:1721–1728CrossRefPubMed
Metadaten
Titel
General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival
verfasst von
Hans Jørgen Aarstad
Arild Andrè Østhus
Helene Hersvik Aarstad
Stein Lybak
Anne Kari Hersvik Aarstad
Publikationsdatum
20.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4800-8

Weitere Artikel der Ausgabe 1/2018

European Archives of Oto-Rhino-Laryngology 1/2018 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.